Found 5 resultsAuthor Title [ Type] Year
Filters: First Letter Of Title is P and Author is Graham, BS [Clear All Filters]
Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV-1 DNA Candidate Vaccine. J Infect Dis, 194, 1650-1660. presented at the 12/2006. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/17109336. (2006).
Phase I Clinical Evaluation of a Six-Plasmid Multiclade HIV-1 DNA Candidate Vaccine. Vaccine, 25, 4085-4092. presented at the 05/2007. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/17391815. (2007).
Phase I Randomized Clinical Trial of VRC DNA and rAd5 HIV-1 Vaccine Delivery by Intramuscular (i.m.), Subcutaneous (s.c.) and Intradermal (i.d.) Administration (VRC 011). PLoS ONE, 9, e91366. presented at the 03/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24621858. (2014).
A Phase II study of two HIV-1 envelope vaccines comparing their immunogenicity in populations at risk for acquiring HIV-1 infection. AIDS Res HumRetroviruses, 16, 907-19. presented at the 2000.. (2000).
Prime-Boost Interval Matters: A Randomized Phase 1 Study to Identify the Minimum Interval Necessary to Observe the H5 DNA Influenza Vaccine Priming Effect. J Infect Dis, 208, 418-422. presented at the 08/2013. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23633407. (2013).